FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3137003596> ?p ?o ?g. }

• W3137003596 endingPage "870" @default.
• W3137003596 startingPage "861" @default.
• W3137003596 abstract "Objective Fenestrated-branched endovascular aneurysm repair (FBEVAR) has expanded the treatment of patients with thoracoabdominal aortic aneurysms (TAAAs). Previous studies have demonstrated that women are less likely to be treated with standard infrarenal endovascular aneurysm repair because of anatomic ineligibility and experience greater mortality after both infrarenal and thoracic aortic aneurysm repair. The purpose of the present study was to describe the sex-related outcomes after FBEVAR for treatment of TAAAs. Methods The data from 886 patients with extent I to IV TAAAs (excluding pararenal or juxtarenal aneurysms), enrolled in eight prospective, physician-sponsored, investigational device exemption studies from 2013 to 2019, were analyzed. All data were collected prospectively, audited and adjudicated by clinical events committees and/or data safety monitoring boards, and subject to Food and Drug Administration oversight. All the patients had been treated with Cook-manufactured patient-specific FBEVAR devices or the Cook t-Branch off-the-shelf device (Cook Medical, Brisbane, Australia). Results Of the 886 patients who underwent FBEVAR, 288 (33%) were women. The women had more extensive aneurysms and a greater prevalence of diabetes (33% vs 26%; P = .043) but a lower prevalence of coronary artery disease (33% vs 52%; P < .0001) and previous infrarenal endovascular aneurysm repair (7.6% vs 16%; P < .001). The women had required a longer operative time from incision to surgery end (5.0 ± 1.8 hours vs 4.6 ± 1.7 hours; P < .001), experienced lower technical success (93% vs 98%; P = .002), and were less likely to be discharged to home (72% vs 83%; P = .009). Despite the smaller access vessels, the women did not have an increased incidence of access site complications. Also, the 30-day outcomes were broadly similar between the sexes. At 1 year, no differences were found between the women and men in freedom from type I or III endoleak (91.4% vs 92.0%; P = .64), freedom from reintervention (81.7% vs 85.3%; P = .10), target vessel instability (87.5% vs 89.2%; P = .31), and survival (89.6% vs 91.7%; P = .26). The women had a greater incidence of postoperative sac expansion (12% vs 6.5%; P = .006). Multivariable modeling adjusted for age, aneurysm extent, aneurysm size, urgent procedure, and renal function showed that patient sex was not an independent predictor of survival (hazard ratio, 0.83; 95% confidence interval, 0.50-1.37; P = .46). Conclusions Women undergoing FBEVAR demonstrated metrics of increased complexity and had a lower level of technical success, especially those with extensive aneurysms. Compared with the men, the women had similar 30-day mortality and 1-year outcomes, with the exception of an increased incidence of sac expansion. These data have demonstrated that FBEVAR is safe and effective for women and men but that further efforts to improve outcome parity are indicated." @default.
• W3137003596 created "2021-03-29" @default.
• W3137003596 creator A5011560616 @default.
• W3137003596 creator A5017352552 @default.
• W3137003596 creator A5028429089 @default.
• W3137003596 creator A5043383232 @default.
• W3137003596 creator A5043875322 @default.
• W3137003596 creator A5044461076 @default.
• W3137003596 creator A5052567263 @default.
• W3137003596 creator A5055611097 @default.
• W3137003596 creator A5069960433 @default.
• W3137003596 creator A5072717081 @default.
• W3137003596 creator A5083298912 @default.
• W3137003596 creator A5089306278 @default.
• W3137003596 creator A5090442172 @default.
• W3137003596 date "2021-09-01" @default.
• W3137003596 modified "2023-10-14" @default.
• W3137003596 title "Sex-related outcomes after fenestrated-branched endovascular aneurysm repair for thoracoabdominal aortic aneurysms in the U.S. Fenestrated and Branched Aortic Research Consortium" @default.
• W3137003596 cites W1971117312 @default.
• W3137003596 cites W1984522888 @default.
• W3137003596 cites W1991063512 @default.
• W3137003596 cites W2020002857 @default.
• W3137003596 cites W2030177465 @default.
• W3137003596 cites W2132107848 @default.
• W3137003596 cites W2135585295 @default.
• W3137003596 cites W2139863969 @default.
• W3137003596 cites W2222930627 @default.
• W3137003596 cites W2239834582 @default.
• W3137003596 cites W2275664693 @default.
• W3137003596 cites W2408270188 @default.
• W3137003596 cites W2442796931 @default.
• W3137003596 cites W2517013661 @default.
• W3137003596 cites W2606083563 @default.
• W3137003596 cites W2621193065 @default.
• W3137003596 cites W2753205305 @default.
• W3137003596 cites W2772011691 @default.
• W3137003596 cites W2791332095 @default.
• W3137003596 cites W2895578378 @default.
• W3137003596 cites W2900837369 @default.
• W3137003596 cites W2901442693 @default.
• W3137003596 cites W2902325811 @default.
• W3137003596 cites W2941322719 @default.
• W3137003596 cites W2947150293 @default.
• W3137003596 cites W2947589513 @default.
• W3137003596 cites W2969834225 @default.
• W3137003596 cites W2970639785 @default.
• W3137003596 cites W2971250949 @default.
• W3137003596 cites W2973716335 @default.
• W3137003596 cites W2983651031 @default.
• W3137003596 cites W2997338152 @default.
• W3137003596 cites W3037104672 @default.
• W3137003596 cites W3041891668 @default.
• W3137003596 doi "https://doi.org/10.1016/j.jvs.2021.02.046" @default.
• W3137003596 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33775747" @default.
• W3137003596 hasPublicationYear "2021" @default.
• W3137003596 type Work @default.
• W3137003596 sameAs 3137003596 @default.
• W3137003596 citedByCount "21" @default.
• W3137003596 countsByYear W31370035962021 @default.
• W3137003596 countsByYear W31370035962022 @default.
• W3137003596 countsByYear W31370035962023 @default.
• W3137003596 crossrefType "journal-article" @default.
• W3137003596 hasAuthorship W3137003596A5011560616 @default.
• W3137003596 hasAuthorship W3137003596A5017352552 @default.
• W3137003596 hasAuthorship W3137003596A5028429089 @default.
• W3137003596 hasAuthorship W3137003596A5043383232 @default.
• W3137003596 hasAuthorship W3137003596A5043875322 @default.
• W3137003596 hasAuthorship W3137003596A5044461076 @default.
• W3137003596 hasAuthorship W3137003596A5052567263 @default.
• W3137003596 hasAuthorship W3137003596A5055611097 @default.
• W3137003596 hasAuthorship W3137003596A5069960433 @default.
• W3137003596 hasAuthorship W3137003596A5072717081 @default.
• W3137003596 hasAuthorship W3137003596A5083298912 @default.
• W3137003596 hasAuthorship W3137003596A5089306278 @default.
• W3137003596 hasAuthorship W3137003596A5090442172 @default.
• W3137003596 hasBestOaLocation W31370035961 @default.
• W3137003596 hasConcept C126322002 @default.
• W3137003596 hasConcept C126838900 @default.
• W3137003596 hasConcept C141071460 @default.
• W3137003596 hasConcept C2776098176 @default.
• W3137003596 hasConcept C2776543907 @default.
• W3137003596 hasConcept C2777323849 @default.
• W3137003596 hasConcept C2778213512 @default.
• W3137003596 hasConcept C2778620186 @default.
• W3137003596 hasConcept C2779993416 @default.
• W3137003596 hasConcept C2780847584 @default.
• W3137003596 hasConcept C3018890749 @default.
• W3137003596 hasConcept C71924100 @default.
• W3137003596 hasConcept C99454951 @default.
• W3137003596 hasConceptScore W3137003596C126322002 @default.
• W3137003596 hasConceptScore W3137003596C126838900 @default.
• W3137003596 hasConceptScore W3137003596C141071460 @default.
• W3137003596 hasConceptScore W3137003596C2776098176 @default.
• W3137003596 hasConceptScore W3137003596C2776543907 @default.
• W3137003596 hasConceptScore W3137003596C2777323849 @default.
• W3137003596 hasConceptScore W3137003596C2778213512 @default.
• W3137003596 hasConceptScore W3137003596C2778620186 @default.
• W3137003596 hasConceptScore W3137003596C2779993416 @default.

• next